Method for treating a pulmonary hypertension condition
AssigneeGilead Sciences, Inc.
InventorsMichael J. Gerber, Christopher Dufton
Life of this patent
Estimating the term…
Abstract
A method for treating a pulmonary hypertension condition such as pulmonary arterial hypertension (PAH) in a subject comprises administering to the subject a therapeutically effective amount of ambrisentan, wherein, at baseline, time from first diagnosis of the condition in the subject is not greater than about 2 years.
Claims15
A method for treating a pulmonary hypertension condition in a human patient, comprising administering to the patient a therapeutically effective amount of ambrisentan and a therapeutically effective amount of an agent selected from the group consisting of sildenafil, tadalafil and vardenafil.
A method for treating pulmonary arterial hypertension (PAH) in a human patient, comprising administering to the patient a therapeutically effective amount of ambrisentan and a therapeutically effective amount of tadalafil.
Dependencies are inferred from the claim text.